Nanostructured lipid system as a strategy to improve the anti-Candida albicans activity of Astronium sp.
Authors Vidal Bonifácio B, dos Santos Ramos MA, Bento da Silva P, Silveira Negri KM, de Oliveira Lopes, Perez de Souza L, Vilegas W, Pavan FR, Chorilli M, Bauab TM
Received 21 December 2014
Accepted for publication 3 April 2015
Published 10 August 2015 Volume 2015:10(1) Pages 5081—5092
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 4
Editor who approved publication: Prof. Dr. Thomas J Webster
Bruna Vidal Bonifácio,1 Matheus Aparecido dos Santos Ramos,1 Patrícia Bento da Silva,2 Kamila Maria Silveira Negri,1 Érica de Oliveira Lopes,1 Leonardo Perez de Souza,3 Wagner Vilegas,4 Fernando Rogério Pavan,1 Marlus Chorilli,2 Taís Maria Bauab1
1Department of Biological Sciences, 2Department of Drugs and Medicines, School of Pharmaceutical Sciences, 3Department of Organic Chemistry, Chemistry Institute, UNESP – Univ Estadual Paulista, Araraquara, São Paulo, Brazil; 4Coastal Campus of São Vicente, UNESP – Univ Estadual Paulista, São Vicente, São Paulo, Brazil
Abstract: The genus Astronium (Anacardiaceae) includes species, such as Astronium fraxinifolium, Astronium graveolens, and Astronium urundeuva, which possess anti-inflammatory, anti-ulcerogenic, healing, and antimicrobial properties. Nanostructured lipid systems are able to potentiate the action of plant extracts, reducing the required dose and side effects and improving antimicrobial activity. This work aims to evaluate a nanostructured lipid system that was developed as a strategy to improve the anti-Candida albicans activity of hydroethanolic extracts of stems and leaves from Astronium sp. The antifungal activity against C. albicans (ATCC 18804) was evaluated in vitro by a microdilution technique. In addition to the in vitro assays, the Astronium sp. that showed the best antifungal activity and selectivity index was submitted to an in vivo assay using a model of vulvovaginal candidiasis infection. In these assays, the extracts were either used alone or were incorporated into the nanostructured lipid system (comprising 10% oil phase, 10% surfactant, and 80% aqueous phase). The results indicated a minimal inhibitory concentration of 125.00 µg/mL before incorporation into the nanostructured system; this activity was even more enhanced when this extract presented a minimal inhibitory concentration of 15.62 µg/mL after its incorporation. In vivo assay dates showed that the nanostructure-incorporated extract of A. urundeuva leaves was more effective than both the unincorporated extract and the antifungal positive control (amphotericin B). These results suggest that this nanostructured lipid system can be used in a strategy to improve the in vitro and in vivo anti-C. albicans activity of hydroethanolic extracts of Astronium sp.
Keywords: plant extract, anticandidal activity, microdilution, microemulsion, vulvovaginal candidiasis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]